Parkman Healthcare Partners LLC Arcellx, Inc. Transaction History
Parkman Healthcare Partners LLC
- $708 Million
- Q3 2024
A detailed history of Parkman Healthcare Partners LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 66,492 shares of ACLX stock, worth $4.53 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
66,492
Previous 156,843
57.61%
Holding current value
$4.53 Million
Previous $8.66 Million
35.86%
% of portfolio
0.78%
Previous 1.28%
Shares
10 transactions
Others Institutions Holding ACLX
# of Institutions
204Shares Held
44.1MCall Options Held
2.23MPut Options Held
907K-
Paradigm Biocapital Advisors LP New York, NY4MShares$273 Million12.04% of portfolio
-
Perceptive Advisors LLC New York, NY3.89MShares$265 Million8.48% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$255 Million23.89% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$240 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$168 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.99B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...